Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.
Amador Bioscience has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Amador Bioscience's investors include Sequoia Capital, MSA Capital, GL Ventures LLC, CMB International Capital Corporation, Cowin Venture.
Amador Bioscience is headquartered in Pleasanton, United States.
Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.
Amador Bioscience is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amador Bioscience — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/amador-bioscience. Accessed October 29, 2026.
VCBacked. (2021). Amador Bioscience — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/amador-bioscience
{{cite web |title=Amador Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/amador-bioscience |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated